Interaction of (+)-Strebloside and Its Derivatives with Na +/K +-ATPase and Other Targets
Reads0
Chats0
TLDR
In this article, the docking profiles for (+)-strebloside, a cytotoxic cardiac glycoside identified from Streblus asper, and some of its derivatives and Na+/K+-ATPase have been investigated.Abstract:
Docking profiles for (+)-strebloside, a cytotoxic cardiac glycoside identified from Streblus asper, and some of its derivatives and Na+/K+-ATPase have been investigated. In addition, binding between (+)-strebloside and its aglycone, strophanthidin, and several of their other molecular targets, including FIH-1, HDAC, KEAP1 and MDM2 (negative regulators of Nrf2 and p53, respectively), NF-κB, and PI3K and Akt1, have been inspected and compared with those for digoxin and its aglycone, digoxigenin. The results showed that (+)-strebloside, digoxin, and their aglycones bind to KEAP1 and MDM2, while (+)-strebloside, strophanthidin, and digoxigenin dock to the active pocket of PI3K, and (+)-strebloside and digoxin interact with FIH-1. Thus, these cardiac glycosides could directly target HIF-1, Nrf2, and p53 protein-protein interactions, Na+/K+-ATPase, and PI3K to mediate their antitumor activity. Overall, (+)-strebloside seems more promising than digoxin for the development of potential anticancer agents.read more
Citations
More filters
Journal ArticleDOI
Discovery of Anticancer Agents of Diverse Natural Origin.
Leslie N. Aldrich,Joanna E. Burdette,Esperanza J. Carcache de Blanco,Christopher C. Coss,Alessandra S. Eustáquio,James R. Fuchs,A. Douglas Kinghorn,Amanda MacFarlane,Brittney K Mize,Nicholas H. Oberlies,Jimmy Orjala,Cedric J. Pearce,Mitch A. Phelps,L. Harinantenaina Rakotondraibe,Yulin Ren,Djaja D. Soejarto,Brent R. Stockwell,Jack C. Yalowich,Xiaoli Zhang +18 more
TL;DR: Research progress from mainly over the last five years is described for a multidisciplinary collaborative program project directed toward the discovery of potential anticancer agents from a broad range of taxonomically defined organisms.
Journal ArticleDOI
Effects of Corchorusoside C on NF-κB and PARP-1 Molecular Targets and Toxicity Profile in Zebrafish
Nathan P. Mirtallo Ezzone,Gerardo D. Anaya-Eugenio,Ermias Mekuria Addo,Yulin Ren,A. Douglas Kinghorn,Esperanza J. Carcache de Blanco +5 more
TL;DR: In this article , a mechanistic study was pursued in a zebrafish model and in DU-145 prostate cancer cells to investigate the selectivity of corchorusoside C (1) towards NF-κB and PARP-1 pathway elements.
Journal ArticleDOI
Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer.
TL;DR: The taxane and camptothecin families represent significant therapeutics currently available for the treatment of ovarian cancer, and new drugs that have alternative mechanisms of action are still needed to combat the disease as mentioned in this paper .
Journal ArticleDOI
The Cytotoxic Cardiac Glycoside (-)-Cryptanoside A from the Stems of Cryptolepis dubia and Its Molecular Targets.
Yulin Ren,Elizabeth N. Kaweesa,L. Tian,Sijin Wu,Kongmany Sydara,Mouachanh Xayvue,Curtis E. Moore,Djaja D. Soejarto,Xiao-hong Cheng,Jianhua Yu,Joanna E. Burdette,A. Douglas Kinghorn +11 more
TL;DR: A cardiac glycoside epoxide, (-)-cryptanoside A (1), was isolated from the stems of Cryptolepis dubia collected in Laos, for which the complete structure was confirmed by analysis of its spectroscopic and single-crystal X-ray diffraction data, using copper radiation at a low temperature as discussed by the authors .
Journal ArticleDOI
Cardiac glycosides from the roots of Streblus asper Lour. with activity against Epstein-Barr virus lytic replication.
Jing Cai,Bo Zhang,Yu-Qi Li,Wanfang Zhu,Toshihiro Akihisa,Takashi Kikuchi,Jian Xu,Wenyuan Liu,Feng Feng,Jie Zhang +9 more
TL;DR: In this paper , the authors reported the isolation of five new (1-5) and eight known (7-13) cardiac glycosides (CGs) from the roots of Streblus asper Lour.
References
More filters
Journal ArticleDOI
Ligand docking and binding site analysis with PyMOL and Autodock/Vina.
Daniel Seeliger,Bert L. de Groot +1 more
TL;DR: An interface between the popular molecular graphics system PyMOL and the molecular docking suites Autodock and Vina is presented and it is demonstrated how the combination of docking and visualization can aid structure-based drug design efforts.
Journal ArticleDOI
ROS and ROS-Mediated Cellular Signaling
TL;DR: This review paper focuses on the pattern of the generation and homeostasis of intracellular ROS, the mechanisms and targets of ROS impacting on cell-signaling proteins, ion channels and transporters, and modifying protein kinase and Ubiquitination/Proteasome System.
Journal ArticleDOI
Nrf2 signaling pathway: Pivotal roles in inflammation.
TL;DR: The members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-κB pathway are discussed.
Journal ArticleDOI
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.
TL;DR: This work implemented Python bindings to facilitate scripting and the development of docking workflows in AutoDock Vina 1.2.0, an effort toward the unification of the features of the autoDock4 and AutoD Dock Vina docking engines.
Journal ArticleDOI
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
TL;DR: This review focuses on the potentially complex molecular mechanisms that link the Nrf2 and NF-κB pathways and the importance of designing more effective therapeutic strategies to prevent or treat a broad range of neurological disorders.
Related Papers (5)
Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta
Jeremy Murray,Zachary Kevin Sweeney,Bryan K. Chan,Mercedesz Balazs,Erin K. Bradley,Georgette Castanedo,Christine Chabot,David Chantry,Michael Flagella,David Michael Goldstein,Rama K. Kondru,John Lesnick,Jun Li,Matthew C. Lucas,Jim Nonomiya,Jodie Pang,Stephen Price,Laurent Salphati,Brian Safina,Pascal Savy,Eileen Mary Seward,Mark Ultsch,Daniel P. Sutherlin +22 more